title: Pulmonary complications associated with pegylated interferon and ribavirin in HIV/hepatitis C virus coinfected patients.
authors.affiliation: Infectious Diseases Unit, A.O. Papa Giovanni XXIII, Bergamo, Italy.
authors.forename: Simone
authors.initials: S
authors.lastname: Vasilij Benatti
authors.forename: Quinzan
authors.initials: Q
authors.lastname: Giampaolo
authors.forename: Bigoni
authors.initials: B
authors.lastname: Sara
authors.forename: Rizzi
authors.initials: R
authors.lastname: Marco
authors.forename: Ripamonti
authors.initials: R
authors.lastname: Diego
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D006976:Hypertension, Pulmonary / Q000139:chemically induced* / Q000175:diagnosis; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D012254:Ribavirin / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin